COMPANIES COVERED
Sanofi (France)Download FREE Report Sample
Download Free sampleClopidogrel, sold as the brandname Plavix among others, is an antiplatelet medication that is used to reduce the risk of heart disease and stroke in those at high risk. It is also used together with aspirin in heart attacks and following the placement of a coronary artery stent. It is taken by mouth.
Clopidogrel Market contains market size and forecasts of Clopidogrel in global, including the following market information:
Global Clopidogrel Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Clopidogrel Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Clopidogrel companies in 2021 (%)
The global Clopidogrel market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
25mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Clopidogrel include Sanofi (France), Shenzhen Salubris Pharmaceuticals (China) and Lepu Medical Technology (China), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Clopidogrel manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Clopidogrel Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Clopidogrel Market Segment Percentages, by Type, 2021 (%)
25mg
75 mg
300 mg
Global Clopidogrel Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Clopidogrel Market Segment Percentages, by Application, 2021 (%)
Hospitals
Private Clinics
Retail Pharmacies
Online Pharmacies
Others
Global Clopidogrel Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Clopidogrel Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Clopidogrel revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Clopidogrel revenues share in global market, 2021 (%)
Key companies Clopidogrel sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Clopidogrel sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi (France)
Shenzhen Salubris Pharmaceuticals (China)
Lepu Medical Technology (China)
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
